Rare diseases
Investigational molecules
Locations
Ulitsa Otets Paisiy 72, 5100 Gorna Oryahovitsa, Bulgaria
Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD in Gorna Oryahovitsa, Bulgaria specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Asthma, Erosive oesophagitis, and other specialisations. This site conducts important research.
The department is investigating bacterial gut infections, aiming to reduce recurrence and improve patient outcomes through innovative antimicrobial and microbiome‑based approaches.
Research is carried out at Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, which currently hosts 29 clinical trials led by 14 investigators.
Studies focus on acute cerebrovascular events, testing thrombolytic agents to extend therapeutic windows and improve functional recovery after stroke.
The site’s cardiovascular program is part of the broader effort at Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD.
A robust pipeline of trials addresses inflammatory bowel conditions and gastro‑esophageal disorders, seeking to induce remission and heal mucosal damage.
Ongoing work is conducted at Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, supporting 29 trials across specialties.
The unit explores immune‑modulating treatments for chronic inflammatory disorders, combining biologics with metabolic agents to enhance efficacy.
These investigations are part of the research portfolio of Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD.
Trials target liver metabolic dysfunction, obesity, and kidney health, evaluating agents that reduce fibrosis, promote weight loss, and slow renal decline.
The metabolic research program operates at Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, contributing to the site’s 29 active trials.
Focused on asthma management, the department evaluates novel biologics and inhaled therapies to improve lung function and biomarkers of inflammation.
Research is carried out at Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, integrating respiratory studies within its broader clinical trial portfolio.
The site conducts antiviral research, particularly in pediatric COVID‑19, to define safe dosing and assess therapeutic benefit in non‑hospitalized patients.
These virus‑focused investigations are part of the work at Multiprofile Hospital For Active Treatment St. Ivan Rilski Gorna Oriahovitsa EOOD, which currently oversees 29 trials.
More sites in Gorna OryahovitsaBulgaria
Clinical trials currently enrolling participants at this site.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
BulgariaA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
BulgariaSafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
BulgariaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
BulgariaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
BulgariaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
BulgariaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
BulgariaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
BulgariaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
BulgariaStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
BulgariaStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
BulgariaA study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.
BulgariaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
